Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Radiotherapy & Radiosurgery
Radiation therapy for brain cancer
What radiation therapy for brain cancer is, how targeted ionizing beams destroy tumour cells while sparing healthy brain tissue, what clinical evidence shows about survival and tumour control, how stereotactic radiosurgery compares with whole-brain radiation, approximate treatment costs in Turkey against the UK, US and Germany, what to expect during sessions, managing side effects, recovery milestones and choosing an accredited cancer hospital.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Radiotherapy & Radiosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Radiation Therapy for Brain Cancer
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Radiation therapy for brain cancer: what it is and how it works
Radiation therapy for brain cancer is an oncological treatment using high-energy ionizing beams—such as X-rays or gamma photons—to damage the DNA of malignant and abnormal cells within the cranial cavity. When radiation fractures their DNA, cancer cells lose the ability to divide and die. Normal brain tissue repairs radiation damage more effectively than tumours, which allows radiation to be delivered in calibrated daily fractions or focused single doses.
Radiotherapy treats primary brain tumours (such as glioblastomas and astrocytomas) and secondary brain metastases from lung, breast, or melanoma cancers. It serves as an adjuvant therapy after surgery, a primary option for inoperable deep tumours, or palliative care to relieve pressure symptoms. This guide details techniques, clinical evidence, recovery milestones, and costs for radiation therapy for brain cancer in Turkey. For other cancer programmes, see our guide to oncology treatments in Turkey.
How does radiation therapy target brain tumours?
Modern cranial radiotherapy pairs high-resolution neuroimaging with computerised 3D dosimetry to deliver maximum radiation to the lesion while sparing normal brain tissue. Treatment planning begins with a simulation session, where contrast-enhanced MRI is fused with planning CT scans. Radiation oncologists and medical physicists outline the tumour volume and define safety margins to cover microscopic extension and minor movement.
Linear accelerators deliver beams using Intensity-Modulated Radiation Therapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT). Computer-controlled multileaf collimators shape beams continuously as the machine rotates around your head. This sculpts radiation tightly to irregular tumour margins with steep dose fall-offs, protecting critical organs like the brainstem, optic chiasm, and hippocampus from damaging doses.
Does radiation therapy for brain cancer work?
Clinical evidence demonstrates that radiation therapy is highly effective for controlling intracranial tumours. For isolated brain metastases, stereotactic radiosurgery achieves local tumour control in 80% to 90% of suitable cases at one year, based on European Society for Medical Oncology (ESMO) and American Society for Radiation Oncology (ASTRO) guidelines. For primary high-grade gliomas, adding postoperative radiotherapy and temozolomide chemotherapy significantly extends survival compared with surgery alone.
However, radiation cannot promise a cure for aggressive high-grade tumours with diffuse microscopic spread. Radiotherapy also cannot restore brain tissue already permanently damaged by tumour invasion. Furthermore, patients may experience pseudoprogression: temporary tissue swelling on early follow-up scans that mimics tumour growth but reflects treatment response rather than recurrence. Specialist neuroradiologists evaluate perfusion scans to confirm true status.
Radiation therapy for brain cancer cost in Turkey compared with the UK, US and Germany
The cost of brain radiotherapy varies with the chosen technology, whether treatment requires a single radiosurgical session or five to six weeks of daily fractions, and supportive medication needs. The table below outlines approximate cost ranges abroad, not fixed clinic quotes. Each hospital confirms pricing after evaluating current MRI scans.
| Country | Approximate cost range |
|---|---|
| Turkey | €4,000 – €12,000 |
| United Kingdom | €9,000 – €25,000 |
| United States | €18,000 – €55,000 |
| Germany | €8,500 – €22,000 |
What influences the radiation therapy for brain cancer price: Stereotactic radiosurgery (SRS) delivered over one to five sessions incurs lower total stay costs than a 30-fraction course of IMRT. In Turkey, medical packages generally cover CT/MRI simulation scans, dosimetry planning, the treatment fractions, specialist consultations, anti-edema medication, and airport transfers. Request an itemised quotation through our free quote service.
Which radiation technique suits your brain tumour type?
The choice of radiation modality depends on tumour size, quantity, location, and histology. Neuro-oncologists rely on three main approaches:
| Radiation technique | Best suited to | Typical limits |
|---|---|---|
| Stereotactic Radiosurgery (SRS / Gamma Knife) | Small, well-defined tumours (under 3–4 cm), single or limited brain metastases, acoustic neuromas, meningiomas | Not suitable for diffuse infiltrative tumours or large lesions causing severe mass effect |
| Tomotherapy & IMRT | Complex, irregularly shaped tumours near critical organs (optic chiasm, brainstem), primary gliomas | Requires multiple daily fractions over several weeks rather than a single session |
| Whole-Brain Radiation Therapy (WBRT) | Multiple widespread brain metastases, leptomeningeal disease, prophylactic cranial irradiation | Higher risk of neurocognitive side effects, fatigue and temporary hair loss |
For concentrated, non-surgical delivery to small lesions, see our guide to gamma knife radiosurgery. For large or irregular tumours near critical nerves, slice-by-slice fan beams provide exceptional precision; read about tomotherapy to see how it operates.
Who is a candidate for brain radiation, and who is not?
Candidacy is determined by a multidisciplinary oncology team based on tumour biology and patient health. Good candidates typically include:
- Adults and children with primary brain malignancies requiring postoperative adjuvant radiotherapy.
- Patients with one to several brain metastases whose primary cancer is stable or controlled.
- Patients with deep, inoperable tumours or medical conditions that rule out open surgery.
- Individuals with a Karnofsky Performance Scale (KPS) score of 70 or higher, indicating good functional independence.
Radiation therapy may be unsuitable or require delay in the following situations:
- Large brain tumours causing immediate herniation or midline shift, where emergency neurosurgery is essential.
- Prior high-dose radiation to the exact same brain area exceeding safe cumulative tissue limits.
- Active intracranial infections or instability preventing the patient from remaining still during sessions.
- First trimester of pregnancy, where fetal scatter radiation risks require alternative management or delay.
What happens during planning and treatment sessions?
Cranial radiotherapy follows four structured steps to ensure millimeter precision and safety throughout the course:
1. Immobilisation and Simulation: A custom thermoplastic mesh mask is molded over your face and head, cooling into a rigid cast that prevents movement without skull pins. While wearing the mask, planning CT and MRI scans are performed.
2. Dosimetry Planning: Medical physicists and oncologists calculate beam angles and dose distribution on specialized software over two to four days, testing the plan on phantom devices before treatment starts.
3. Treatment Delivery: You lie on the couch with your mask fastened. Adults do not need anaesthesia; beam delivery causes no physical sensation and is silent apart from the quiet mechanical rotation of the machine. Daily imaging verifies position before beams activate for two to five minutes. Total session time is 15 to 30 minutes.
4. Discharge: Once finished, the mask is detached and you return to your hotel or residence. Treatment is performed on an outpatient basis.
Scans and results: what does before and after treatment look like?
In neuro-oncology, radiation therapy for brain cancer before and after evaluation relies on serial MRI scans and clinical neurological checks rather than visual physical transformations. The primary goal is tumour control: shrinking the tumour, stopping growth, or eliminating active blood supply.
Follow-up contrast MRI scans performed two to three months post-treatment typically show reduced contrast uptake and central necrosis within the tumour. Some patients experience pseudoprogression—temporary swelling on early scans that mimics tumour enlargement but represents a harmless inflammatory response to cell destruction. Specialist neuroradiologists review perfusion imaging to distinguish pseudoprogression from true recurrence.
Your medical trip to Turkey, side-effect management and recovery
The length of your stay for radiation therapy for brain cancer Turkey depends on the delivery method. For stereotactic radiosurgery (SRS), a visit of five to seven days is usually sufficient for mask fitting, simulation, planning, treatment, and follow-up. For conventional fractionated radiotherapy, patients stay five to six weeks to complete daily weekday sessions.
During radiation therapy for brain cancer recovery, common acute side effects include gradual fatigue, mild headache, scalp tenderness, and patchy hair thinning in the beam path. Brain swelling is managed with short courses of corticosteroids like dexamethasone. Most patients manage gentle daily walks throughout treatment. Fatigue usually peaks two weeks after the final fraction before easing over six to twelve weeks.
Risks and potential complications of brain radiotherapy
Modern radiotherapy targets tumours accurately, but potential complications exist. Clinical authorities such as the National Health Service (NHS), National Institute for Health and Care Excellence (NICE), and European Society for Radiotherapy and Oncology (ESTRO) categorize risks by timeframe:
- Acute risks (during treatment): Brain swelling causing headache, nausea, or temporary weakness; scalp irritation; patchy hair loss in treated areas; and fatigue.
- Subacute risks (1 to 6 months post-treatment): Somnolence syndrome, causing fatigue and cognitive slowing, which resolves spontaneously.
- Late risks (6 months to years post-treatment): Radiation necrosis (focal tissue death occurring in 3% to 10% of radiosurgery cases); neurocognitive changes affecting memory; and pituitary hormone deficiencies requiring replacement therapy.
Accredited cancer centres maintain 24-hour neuro-oncology teams to manage acute pressure changes or seizures promptly.
How to choose an oncology centre in Turkey, red flags and questions to ask
Selecting an oncology provider for cranial radiotherapy requires verifying international hospital accreditation (such as JCI) and modern linear accelerators. Confirm that the centre operates a Multidisciplinary Tumour Board (MDT) where neurosurgeons, radiation oncologists, and physicists jointly review every case. Learn more on our how it works page or request an assessment via our free quote form.
Watch for red flags: promises of a cure for high-grade malignant tumours, quotes given without reviewing original MRI DICOM files, and clinics without on-board image guidance or 24-hour emergency neurosurgical cover.
Questions to ask your oncology team:
- Will my case be reviewed by a multidisciplinary tumour board including a neurosurgeon?
- Which radiation technique do you recommend for my tumour, and why?
- How will critical structures like my brainstem and optic nerves be shielded?
- What image guidance is used on the couch to verify precision daily?
- What emergency protocols exist if I experience acute swelling or seizures?
- What follow-up scan schedule do you advise once I return home?
Conditions treated with Radiation Therapy for Brain Cancer
Hospitals with Oncology in Turkey
Frequently asked questions
Radiation therapy for brain cancer uses focused high-energy ionizing beams, such as X-rays or gamma rays, to damage the DNA of cancer cells in the brain. This stops them from multiplying and causes them to die. Modern techniques shape the beams with sub-millimeter precision to protect healthy surrounding brain tissue.
Yes, it is an established pillar of brain cancer management. For brain metastases, stereotactic radiosurgery achieves local tumour control in over 80% to 90% of suitable cases. For primary gliomas, radiation combined with chemotherapy significantly improves progression-free and overall survival compared with surgery alone, though curative outcomes depend heavily on tumour grade and molecular type.
In Turkey, brain radiotherapy typically costs between €4,000 and €12,000, depending on whether treatment requires a single radiosurgical session or a multi-week fractionated course. This compares with €9,000 to €25,000 in the UK and up to €55,000 in the US. Each hospital provides an itemised price after reviewing your MRI scans.
Success is measured through follow-up MRI scans rather than visible physical changes. Over two to six months, scans typically show tumour shrinkage or a non-enhancing necrotic centre. In some patients, temporary swelling called pseudoprogression mimics tumour growth before stabilising, requiring evaluation by experienced neuroradiologists.
Recovery depends on the technique. Patients having single-session radiosurgery often resume routine light activities within two to three days. Those completing five to six weeks of fractionated radiotherapy face cumulative fatigue and mild scalp irritation that peak shortly after treatment ends and gradually resolve over six to twelve weeks with adequate rest and hydration.
The radiation beam itself causes no physical sensation during delivery. You will only hear the quiet mechanical hum of the machine. Discomfort is generally limited to wearing the snug thermoplastic immobilisation mask and mild temporary scalp tenderness, fatigue, or headaches in the days following treatment.
Tumour DNA damage is permanent. For benign lesions and many isolated metastases, radiosurgery provides durable long-term or permanent control. In aggressive primary tumours like glioblastoma, radiotherapy delays progression and prolongs survival, though periodic MRI surveillance remains essential because microscopic tumour cells can eventually recur.
Modern neuro-oncology uses computerised 3D planning, image guidance, and steep dose fall-offs to maximise safety. While acute brain swelling, fatigue, and hair loss can occur, serious late complications like radiation necrosis occur in only 3% to 10% of cases and are proactively monitored and managed by the oncology team.
Stereotactic radiosurgery delivers intense, highly focused doses to small, well-defined tumours in one to five sessions while sparing healthy tissue. Whole-brain radiation covers the entire intracranial area to treat widespread micro-metastases, but carries a higher risk of fatigue, temporary hair loss, and gradual neurocognitive changes.
For stereotactic radiosurgery (SRS or Gamma Knife), plan for five to seven days in Turkey to complete mask fitting, imaging simulation, quality-assurance planning, and post-session observation. For fractionated radiotherapy, patients stay five to six weeks, or attend in structured blocks coordinated with their domestic healthcare team.
Patient stories